FIELD: experimental medicine, cardiology.
SUBSTANCE: one should perform occlusion of descending branch of left coronary artery in its middle third in narcotized cats. But 20 min before occlusion one should introduce polymeric water-soluble analog of acetylsalicylic acid. Due to applying such an antiaggregant one should observe improved cardio- and hemodynamics.
EFFECT: higher efficiency of prophylaxis and therapy.
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT ELICITING ANTI-ISCHEMIC, HYPOTENSIVE, ANTI- -ARRHYTHMIC AND NOOTROPIC ACTIVITY | 2002 |
|
RU2216322C1 |
| METHOD FOR PREVENTING THROMBOSIS AND EMBOLISM | 2002 |
|
RU2241464C2 |
| APPLICATION OF GHRP-6 AS A CARDIOPROTECTIVE AND CARDIORESTORATIVE MEDICINAL PRODUCT FOR LATE TREATMENT | 2019 |
|
RU2779835C1 |
| CARDIOPROTECTIVE, ANTIARRHYTHMIC ANTI-ISHEMIC AGENT | 2007 |
|
RU2366426C2 |
| 2-MERCAPTOBENZIMIDAZOLE DERIVATIVES SHOWING ANTI-ISCHEMIC, ANTI-ARRHYTHMIC AND ANTIFIBRILLATORY ACTIVITY | 1995 |
|
RU2136667C1 |
| APPLICATION OF VASOPEPTIDASE INHIBITOR FOR TREATING STENOCARDIA | 2000 |
|
RU2245147C2 |
| AGENT FOR TREATMENT OF PATIENT WITH HEART ISCHEMIC DISEASE | 1998 |
|
RU2155036C2 |
| AGENT HAVING CARDIOTONIC ACTIVITY | 2012 |
|
RU2521213C1 |
| METHOD FOR TREATING PATIENTS WITH ISCHEMIC CARDIAC DISEASE, STABLE STENOCARDIA IN COMBINATION WITH ARTERIAL HYPERTENSION | 2005 |
|
RU2294741C1 |
| AGENT IMPROVING CARDIAC RESISTANCE TO ISCHEMIC AND FOLLOWING REPERFUSION INJURIES | 2012 |
|
RU2488404C1 |
